Clinical Trials · NCT06490328
Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Dongkook Pharmaceutical Co., Ltd.
- Enrollment
- 161
- Start date
- May 2024
- Locations
- 8 sites, South Korea
- Primary endpoint
- Percentage of participants